O
PRAH

OppenheimerFunds’s PRA Health Sciences, Inc. PRAH Stock Holding History

OppenheimerFunds’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$64.4M Buy
583,614
+62,224
+12% +$6.5M 0.08% 250
2018
Q4 		$47.9M Buy
521,390
+44,513
+9% +$4.5M 0.07% 279
2018
Q3 		$52.5M Buy
476,877
+26,569
+6% +$2.77M 0.06% 316
2018
Q2 		$42M Sell
450,308
-53,786
-11% -$4.63M 0.05% 372
2018
Q1 		$41.8M Buy
504,094
+31,587
+7% +$2.81M 0.05% 364
2017
Q4 		$43M Buy
472,507
+16,947
+4% +$1.41M 0.05% 347
2017
Q3 		$34.7M Sell
455,560
-9,538
-2% -$721K 0.04% 396
2017
Q2 		$34.9M Buy
465,098
+57,290
+14% +$3.97M 0.04% 398
2017
Q1 		$26.6M Buy
407,808
+91,288
+29% +$5.38M 0.03% 487
2016
Q4 		$17.4M Buy
316,520
+131,250
+71% +$7.2M 0.02% 613
2016
Q3 		$10.5M Buy
+185,270
New +$9.09M 0.01% 727

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

OppenheimerFunds's PRAH Position: Q1 2019 in Review

OppenheimerFunds increased its PRA Health Sciences, Inc. (PRAH) stake by 12% in Q1 2019, buying an estimated $6.5M and bringing the position to 583,614 shares worth $64.4M. The position accounts for 0.08% of the portfolio, ranked #250.

OppenheimerFunds first reported a position in PRAH in Q3 2016 and has held it in 11 quarters since. 354 funds tracked by Wall St. Rank hold PRAH as of Q1 2019.

  • OppenheimerFunds held 583,614 shares of PRA Health Sciences, Inc. worth $64.4M as of Q1 2019.
  • OppenheimerFunds bought 62,224 PRA Health Sciences, Inc. shares in Q1 2019, an estimated $6.5M.
  • PRA Health Sciences, Inc. made up 0.08% of OppenheimerFunds's portfolio in Q1 2019, its #250 holding.
  • OppenheimerFunds first reported a position in PRA Health Sciences, Inc. in Q3 2016 and has held it in 11 quarters since.
  • 354 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.